Invention Publication
- Patent Title: PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES MEDIATED BY KDM1A
-
Application No.: US18188578Application Date: 2023-03-23
-
Publication No.: US20230293495A1Publication Date: 2023-09-21
- Inventor: Amy TAPPER , Cassandra CELATKA , Patricia SOULLIAC , Parag VED , Namrata VORA
- Applicant: Imago Biosciences, Inc.
- Applicant Address: US CA San Carlos
- Assignee: Imago Biosciences, Inc.
- Current Assignee: Imago Biosciences, Inc.
- Current Assignee Address: US CA San Carlos
- Main IPC: A61K31/4192
- IPC: A61K31/4192 ; A61K9/20
Abstract:
Provided is a pharmaceutical composition comprising: N—((S)-5-((1R,2S)-2-(4-fluorophenyl)cyclopropylamino)-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl)-4-(1H-1,2,3-triazol-1-yl)benzamide (Compound A), or a pharmaceutically acceptable salt thereof, and at least one stabilizer, pharmaceutical preparations thereof, and methods for the treatment a disease or disorder associated with KDM1A activity.
Information query
